文献速递真菌感染细菌感染、耐药与抗菌药物

中国念珠菌血症病原分布与抗真菌药敏:CHIF-NET更新

Distribution and Antifungal Susceptibility of Candida Species Causing Candidemia in China: An Update From the CHIF-NET Study.
PubMed 文献 · J Infect Dis · 2020-01-01

CHIF-NET研究覆盖中国77家医院3年,收集4010株念珠菌血症分离株,以质谱和DNA测序鉴定菌种、CLSI微量肉汤稀释法测药敏。非白念珠菌占三分之二以上,以近平滑念珠菌复合群、热带念珠菌和光滑念珠菌复合群为主;热带念珠菌和光滑念珠菌唑类耐药值得关注,少见菌种出现共耐药和多药耐药。

要点

  • 非白念珠菌占念珠菌血症分离株三分之二以上,经验用药需覆盖非白念珠菌。
  • 热带念珠菌氟康唑耐药率和光滑念珠菌伏立康唑敏感性下降需动态监测。
  • 少见念珠菌如C. pelliculosa和C. haemulonii可出现共耐药或多药耐药。

核心结论

  • 非白念珠菌是中国念珠菌血症的主要病原,热带念珠菌和光滑念珠菌唑类耐药突出,少见菌种已出现共耐药和多药耐药。

研究设计与样本

  • 中国77家医院为期3年的念珠菌血症监测研究,共收集4010株念珠菌分离株。
  • 菌种鉴定采用质谱和DNA测序,药敏采用CLSI微量肉汤稀释法。

主要发现

  • 非白念珠菌占分离株三分之二以上,以近平滑念珠菌复合群27.1%、热带念珠菌18.7%、光滑念珠菌复合群12.0%为主。
  • 多数白念珠菌和近平滑念珠菌复合群对全部抗真菌药敏感,耐药率低于5%。
  • 3年间光滑念珠菌狭义种对伏立康唑敏感性下降,热带念珠菌氟康唑耐药率增至三倍。
  • 超过三分之一的C. pelliculosa分离株对氟康唑和5-氟胞嘧啶共耐药,超过56%的C. haemulonii分离株为多药耐药。

关键数值与推荐

  • 近平滑念珠菌复合群占27.1%,热带念珠菌占18.7%,光滑念珠菌复合群占12.0%。
  • 白念珠菌和近平滑念珠菌复合群对全部抗真菌药耐药率低于5%。
  • 超过三分之一的C. pelliculosa对氟康唑和5-氟胞嘧啶共耐药,超过56%的C. haemulonii多药耐药。

临床怎么用

  • 中国念珠菌血症经验性抗真菌治疗应覆盖非白念珠菌,并参考当地耐药监测数据。
  • 对热带念珠菌和光滑念珠菌感染应关注唑类耐药,必要时行药敏试验指导治疗。
  • 检出少见念珠菌时需警惕共耐药或多药耐药,避免盲目经验用药。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Candidemia is the most common, serious fungal infection and Candida antifungal resistance is a challenge. We report recent surveillance of candidemia in China. METHODS: The study encompassed 77 Chinese hospitals over 3 years. Identification of Candida species was by mass spectrometry and DNA sequencing. Antifungal susceptibility was determined using the Clinical and Laboratory Standards Institute broth microdilution method. RESULTS: In total, 4010 isolates were collected from candidemia patients. Although C. albicans was the most common species, non-albicans Candida species accounted for over two-thirds of isolates, predominated C. parapsilosis complex (27.1%), C. tropicalis (18.7%), and C. glabrata complex (12.0%). Most C. albicans and C. parapsilosis complex isolates were susceptible to all antifungal agents (resistance rate <5%). However, there was a decrease in voriconazole susceptibility to C. glabrata sensu stricto over the 3 years and fluconazole resistance rate in C. tropicalis tripled. Amongst less common Candida species, over one-third of C. pelliculosa isolates were coresistant to fluconazole and 5-flucytocine, and >56% of C. haemulonii isolates were multidrug resistance. CONCLUSIONS: Non-albicans Candida species are the predominant cause of candidemia in China. Azole resistance is notable amongst C. tropicalis and C. glabrata. Coresistance and multidrug resistance has emerged in less common Candida species.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Xiao M, Chen SC, Kong F, et al. Distribution and Antifungal Susceptibility of Candida Species Causing Candidemia in China: An Update From the CHIF-NET Study. J Infect Dis. 2020. PMID: 32176789. doi:10.1093/infdis/jiz573

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。